Aarti Drugs fundamental analysis

AARTIDRUGS

367.75

22.85 (-5.85%)
Last updated on 4 Feb, 2026 | 13:28 IST
alert_iconwatchlist_icon
BUYSELL

alert_iconThe current prices are delayed, login to your account for live prices

Aarti Drugs Fundamentals

P/E Ratio

17.65

P/B Ratio

2.43

Div. Yield

0.26

Sector P/E

67.04

Sector P/B

1.38

Sec. Div. Yield

0.58

Aarti Drugs Fundamentals is currently trading with a P/E Ratio of 17.65, compared to the sector average of 67.04. Its P/B Ratio stands at 2.43, while the sector’s is 1.38. In terms of returns, the stock offers a Dividend Yield of 0.26%, which is than the sector’s 0.58%.

Aarti Drugs Score Card

  • price_icon
    Price

    Attractive

  • chart_icon
    Growth

    Moderate

  • quality_check
    Quality

    Average

  • quality_check
    Management

    Good

On its scorecard, Aarti Drugs reflects: Price – Attractive, Growth – Moderate, Quality – Average, and Management – Good. Together, these indicators provide a structured view of the company’s fundamentals.